High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma
Abstract Background PDZ-binding kinase (PBK) encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. There is evidence that overexpression of this gene is associated with tumorigenesis. However, the role of PBK in hepatocellular...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-021-02479-w |
_version_ | 1818954037257568256 |
---|---|
author | Wei Mu Yaoli Xie Jinhu Li Runzhi Yan Jingxian Zhang Yu’e Liu Yimin Fan |
author_facet | Wei Mu Yaoli Xie Jinhu Li Runzhi Yan Jingxian Zhang Yu’e Liu Yimin Fan |
author_sort | Wei Mu |
collection | DOAJ |
description | Abstract Background PDZ-binding kinase (PBK) encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. There is evidence that overexpression of this gene is associated with tumorigenesis. However, the role of PBK in hepatocellular carcinoma (HCC) remains unclear. Therefore, we evaluated the prognostic role of PBK and its correlation with immune infiltrates in hepatocellular carcinoma. Methods The expression of PBK in pan-cancers was studied by Onconmine and TIMER. The expression of PBK in HCC patients and its relationship with clinicopathological characteristics were analyzed using The Gene Expression Profiling Interactive Analysis (GEPIA), The human protein atlas database (HPA), The Cancer Genome Atlas (TCGA), and Gene Expression Omnibus (GEO) databases. Receiver operating characteristic (ROC) curve was used to determine the diagnostic value of PBK in HCC patients. The relationship between PBK and prognosis of HCC was performed by GEPIA and Kaplan Meier plotter web tool. The correlations between the clinical characteristics and overall survival were analyzed by Univariate Cox regression and Multivariate Cox hazards regression to identify possible prognostic factors for HCC patients. LinkedOmics was applied to investigate co-expression associated with PBK and to analyze Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The network map of PBK and related genes is constructed by GeneMANIA. Finally, TIMER and TISIDB were used to analyze the correlations between PBK and tumor-infiltrating immune cells. Results Multiple database analysis shows that PBK was highly expressed in many types of tumors, including hepatocellular carcinoma, and was significantly related to tumor stage (P=0.0089), age (P=0.0131), and race (P=0.0024) of HCC patients. The receiver operating characteristic (ROC) curve analysis showed that PBK had high diagnostic potential to HCC in GSE76427 (AUC=0.8799), GSE121248 (AUC=0.9224), GSE62232 (AUC=0.9975), and GSE84402 (AUC=0.9541). Multivariate Cox hazards regression showed that high expression of PBK may be an independent risk factor for overall survival in HCC patients (HR = 1.566, 95% CI=1.062–2.311, P= 0.024). The Protein–protein interaction network showed that PBK significantly interacted with LRRC47, ARAF, LGALS9B, TTK, DLG1, and other essential genes. Furthermore, enrichment analysis showed that PBK and co-expressed genes participated in many biological processes, cell composition, molecular functions, and pathways in HCC. Finally, the immune infiltration analysis by TIMER and TISIDB indicated that a significant tightly correlation between PBK and macrophages, neutrophils, as well as chemokines and receptors. Conclusions High expression of PBK is significantly correlated with poor survival and immune infiltrates in hepatocellular carcinoma. Our study suggests that PBK can be used as a biomarker of poor prognosis and potential immune therapy target in hepatocellular carcinoma. |
first_indexed | 2024-12-20T10:15:48Z |
format | Article |
id | doaj.art-3ca73d3117094855bb63d6fdda512d40 |
institution | Directory Open Access Journal |
issn | 1477-7819 |
language | English |
last_indexed | 2024-12-20T10:15:48Z |
publishDate | 2022-01-01 |
publisher | BMC |
record_format | Article |
series | World Journal of Surgical Oncology |
spelling | doaj.art-3ca73d3117094855bb63d6fdda512d402022-12-21T19:44:04ZengBMCWorld Journal of Surgical Oncology1477-78192022-01-0120111310.1186/s12957-021-02479-wHigh expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinomaWei Mu0Yaoli Xie1Jinhu Li2Runzhi Yan3Jingxian Zhang4Yu’e Liu5Yimin Fan6Department of Neurosurgery, The First Hospital of Shanxi Medical UniversityDepartment of Physiology, Shanxi Medical UniversityDepartment of Neurosurgery, The First Hospital of Shanxi Medical UniversityDepartment of Neurosurgery, The First Hospital of Shanxi Medical UniversityDepartment of Interventional Radiology, Shanxi Provincial People’s HospitalDepartment of Interventional Radiology, Shanxi Provincial People’s HospitalDepartment of Neurosurgery, The First Hospital of Shanxi Medical UniversityAbstract Background PDZ-binding kinase (PBK) encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. There is evidence that overexpression of this gene is associated with tumorigenesis. However, the role of PBK in hepatocellular carcinoma (HCC) remains unclear. Therefore, we evaluated the prognostic role of PBK and its correlation with immune infiltrates in hepatocellular carcinoma. Methods The expression of PBK in pan-cancers was studied by Onconmine and TIMER. The expression of PBK in HCC patients and its relationship with clinicopathological characteristics were analyzed using The Gene Expression Profiling Interactive Analysis (GEPIA), The human protein atlas database (HPA), The Cancer Genome Atlas (TCGA), and Gene Expression Omnibus (GEO) databases. Receiver operating characteristic (ROC) curve was used to determine the diagnostic value of PBK in HCC patients. The relationship between PBK and prognosis of HCC was performed by GEPIA and Kaplan Meier plotter web tool. The correlations between the clinical characteristics and overall survival were analyzed by Univariate Cox regression and Multivariate Cox hazards regression to identify possible prognostic factors for HCC patients. LinkedOmics was applied to investigate co-expression associated with PBK and to analyze Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The network map of PBK and related genes is constructed by GeneMANIA. Finally, TIMER and TISIDB were used to analyze the correlations between PBK and tumor-infiltrating immune cells. Results Multiple database analysis shows that PBK was highly expressed in many types of tumors, including hepatocellular carcinoma, and was significantly related to tumor stage (P=0.0089), age (P=0.0131), and race (P=0.0024) of HCC patients. The receiver operating characteristic (ROC) curve analysis showed that PBK had high diagnostic potential to HCC in GSE76427 (AUC=0.8799), GSE121248 (AUC=0.9224), GSE62232 (AUC=0.9975), and GSE84402 (AUC=0.9541). Multivariate Cox hazards regression showed that high expression of PBK may be an independent risk factor for overall survival in HCC patients (HR = 1.566, 95% CI=1.062–2.311, P= 0.024). The Protein–protein interaction network showed that PBK significantly interacted with LRRC47, ARAF, LGALS9B, TTK, DLG1, and other essential genes. Furthermore, enrichment analysis showed that PBK and co-expressed genes participated in many biological processes, cell composition, molecular functions, and pathways in HCC. Finally, the immune infiltration analysis by TIMER and TISIDB indicated that a significant tightly correlation between PBK and macrophages, neutrophils, as well as chemokines and receptors. Conclusions High expression of PBK is significantly correlated with poor survival and immune infiltrates in hepatocellular carcinoma. Our study suggests that PBK can be used as a biomarker of poor prognosis and potential immune therapy target in hepatocellular carcinoma.https://doi.org/10.1186/s12957-021-02479-wPDZ-binding kinase (PBK)Hepatocellular carcinoma (HCC)Tumor-infiltrating immune cells (TIICs)Bioinformatics analysisSignaling pathways |
spellingShingle | Wei Mu Yaoli Xie Jinhu Li Runzhi Yan Jingxian Zhang Yu’e Liu Yimin Fan High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma World Journal of Surgical Oncology PDZ-binding kinase (PBK) Hepatocellular carcinoma (HCC) Tumor-infiltrating immune cells (TIICs) Bioinformatics analysis Signaling pathways |
title | High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma |
title_full | High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma |
title_fullStr | High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma |
title_full_unstemmed | High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma |
title_short | High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma |
title_sort | high expression of pdz binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma |
topic | PDZ-binding kinase (PBK) Hepatocellular carcinoma (HCC) Tumor-infiltrating immune cells (TIICs) Bioinformatics analysis Signaling pathways |
url | https://doi.org/10.1186/s12957-021-02479-w |
work_keys_str_mv | AT weimu highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma AT yaolixie highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma AT jinhuli highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma AT runzhiyan highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma AT jingxianzhang highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma AT yueliu highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma AT yiminfan highexpressionofpdzbindingkinaseiscorrelatedwithpoorprognosisandimmuneinfiltratesinhepatocellularcarcinoma |